PR’s image problem prompts agency name change
October 29, 2003Medical Communications
The pharmaceutical industry's negative view of PR has persuaded healthcare agency Jo Spink Public Relations to re-brand itself as Spink …
Humira one step closer to European market
October 29, 2003Sales and Marketing
Abbott Labs' human monoclonal antibody Humira has received a positive opinion from the EMEA for the treatment of rheumatoid arthritis, …
Delayed Celebrex successor approved in Europe
October 29, 2003Sales and Marketing
Pfizer's follow up to its multi-billion dollar painkiller Celebrex has been approved for marketing across the European Union following a …
MCA playing russian roulette with lives, says charity
October 29, 2003Sales and Marketing
Mental health charity MIND has criticised the way the Medicines Control Agency handles drug regulation, saying it is "playing Russian …
Milburn says ‘not yet’ to foundation PCTs
October 29, 2003Sales and Marketing
Mental health and primary care trusts could eventually take on foundation status, according to Health Secretary Alan Milburn.He said he …
Prescribing one of ten ‘key roles’ for Allied Health Professionals
October 29, 2003Allied Health Professionals are to be encouraged to play a greater role in prescribing as part of a new government …
Omeprazole could be first in wave of blockbuster switches
October 29, 2003OTC
Omeprazole, the blockbuster ulcer drug discovered by AstraZeneca, could soon be dispensed by pharmacists without a prescription, pending final approval …
Lilly rapped for Cialis’ premature marketing
October 29, 2003Sales and Marketing
Eli Lilly has been publicly reprimanded for bringing the pharmaceutical industry into disrepute after promoting its erectile dysfunction treatment Cialis …
US Court ruling could be $7bn blow to industry
October 29, 2003Sales and Marketing
A ruling by the US Supreme Court could clear the way for US states to enforce hugely increased prescription price …
Levitra becomes Viagra’s first US challenger
October 29, 2003Sales and Marketing
GlaxoSmithKline and Bayer's erectile dysfunction is to become Viagra's first major competitor in the US after receiving marketing approval.Launched in …
Schering-Plough sacrifices begin with Hassan’s bonus
October 29, 2003Sales and Marketing
Schering-Plough's new chief executive and chairman Fred Hassan, has forgone a bonus of up to $2 million bonus to demonstrate …
Call for free price-setting across Europe
October 29, 2003Sales and Marketing
Pharmaceutical companies should be allowed to set their own prices in all the European Union countries in order to bring …
Pharmacovigilance careers opportunities
October 28, 2003Business Services pharmacovigilance, recruitment
The relationship between regulatory authorities and pharmaceutical companies may at first glance appear to be pulling in different directions, but …
The new GP contract
October 28, 2003GP contract, NHS, healthcare
The new GP contract was supported by a massive 79 per cent of those GPs who voted for it, despite …
Latest content
FibroFind appoints Lee Borthwick as CEO
